Kronik Obstrüktif Akciğer Hastalarında COVID-19’un Günlük Yaşam Aktiviteleri ve Hastalık Semptomları Üzerine Etkisi

Yıl 2023, Cilt: 16 Sayı: 3, 220 - 227, 30.12.2023

Neşe Özdemir Halil Alkan

https://doi.org/10.52976/vansaglik.1277873

Öz

Amaç: Bu araştırma, kronik obstrüktif akciğer hastalarında COVID-19’un günlük yaşam aktiviteleri ve hastalık semptomları üzerine etkisini incelemek amacıyla yapıldı.
Materyal ve Metot: Tanımlayıcı, kesitsel türde yapılan araştırma Haziran 2022- Eylül 2022 tarihleri arasında X Devlet Hastanesi Göğüs Hastalıkları polikliniğe başvuran 199 KOAH hastası ile yürütüldü. Araştırmanın verileri; Hasta Tanılama Formu, KATZ Günlük Yaşam Aktiviteleri Ölçeği (GYAÖ), KOAH Değerlendirme Testi (CAT), Değiştirilmiş Tıbbi Araştırma Konseyi (MMRC) ölçeği ile toplandı.
Bulgular: COVID-19 geçiren KOAH’lı hastalar ile COVID-19 geçirmeyen KOAH hastaların günlük yaşam aktiviteleri ve hastalık semptom düzeyleri karşılaştırıldığında GYA ve CAT toplam skorları açısından istatistiksel olarak fark bulundu (p<0.05). Grupların MMRC ölçeği puan ortalaması açısından aralarında anlamlı bir farklılık saptanmadı (p>0.05).
Sonuç: COVID-19 geçiren KOAH’lı hastalar COVID-19 geçirmeyen KOAH hastalarına göre daha düşük GYA’ya sahip olmakla birlikte, daha şiddetli hastalık semptom düzeylerine (nefes darlığı, öksürük, balgam, uyuma, yorgunluk gibi) sahip olduğu belirlendi. COVID-19 geçiren KOAH’lı hastalar daha uzun süreli takip edilerek hastalık semptomlarını azaltma ve GYA geliştirme açısından daha fazla desteklenmelidir.

Anahtar Kelimeler

KOAH, COVID-19, Günlük yaşam aktiviteleri, semptomlar

Kaynakça

• Agrawal S, Makuch S, Dróżdż M, Strzelec B, Sobieszczańska M, Mazur G. (2021).The impact of the COVID-19 emergency on life activities and delivery of healthcare services in the elderly population. Journal of Clinical Medicine, 10 (18), 4089.
• Ahmed MS, Neyaz A, Aslami AN. (2016). Health-related quality of life of chronic obstructive pulmonary disease patients: Results from a community based cross-sectional study in Aligarh, Uttar Pradesh, India. Lung India, 33(2), 148.
• Al Chikhanie Y, Veale D, Schoeffler M, Pépin JL, Verges S, Hérengt F. (2021). Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respiratory Physiology & Neurobiology, 287, 103639.
• Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS et al. (2020). Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PloS One, 15(5), e0233147.
• Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M et al. (2022). European Respiratory Society statement on long COVID follow-up. European Respiratory Journal, 60(2), 2102174.
• Antúnez MG, Míguez AM, Estrada ADB, de la Calle GM, Monge DM, Boixeda R et al (2020). Clinical characteristics and prognosis of COPD patients hospitalized with SARS-CoV-2. International Journal of Chronic Obstructive Pulmonary Disease,15, 3433-3445.
• Attaway AA, Zein J, Hatipoğlu US. (2020). SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry. EClinical Medicine, 26, 100515.
• Aul R, Gates J, Draper A, Dunleavy A, Ruickbie S, Meredith H et al. (2021). Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis. Respiratory Medicine, 188, 106602.
• Bakan G. (2021). COVID-19 pandemi sürecinde KOAH olan bireylerin yaşam deneyimleri: Nitel bir çalışma. Genel Sağlık Bilimleri Dergisi, 3(3), 189-199.
• Balkissoon R. (2020). Journal club—severe acute respiratory syndrome coronavirus-2: ımpact on COPD patients. Chronic obstructive pulmonary diseases: Journal of the COPD Foundation, 7(4), 413.
• Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S et al . (2020). Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. European Respiratory Journal, 56(4), 2002096.
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. (1999). Usefulness of the medical research council (mrc) dyspnoea scale As a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7), 581-586.
• Castilla J, Guevara M, Miqueleiz A, Baigorria F, Ibero-Esparza C, Navascués A et al. (2021). Risk factors of infection, hospitalization and death from SARS-CoV-2: a population-based cohort study. Journal of Clinical Medicine, 10(12), 2608.
• Cookson W, Moffatt M, Rapeport G, Quint JA .(2022). Pandemic lesson for global lung diseases: exacerbations are preventable. American Journal of Respiratory and Critical Care Medicine, 205 (11),1271-1280.
• Davies GA, Alsallakh MA, Sivakumaran S, Vasileiou E, Lyons RA, Robertson C et al.(2021). Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax, 76(9), 867-873.
• Daynes E, Gerlis C, Briggs-Price S, Jones P, Singh SJ. (2021). COPD assessment test for the evaluation of COVID-19 symptoms. Thorax, 76(2), 185-187.
• Fettes L, Bayly J, de Bruin LM, Patel M, Ashford S, Higginson IJ et al. (2021). Relationships between prolonged physical and social isolation during the COVID-19 pandemic, reduced physical activity and disability in activities of daily living among people with advanced respiratory disease. Chronic Respiratory Disease, 18, 1-11.
• Fletcher C. (1952). The clinical diagnosisof pulmonary emphysema: An experimental study. Proceedings of the Royal Society of Medicine, 45 (9), 577-584.
• George D, Mallery M. (2010). SPSS for Windows step by step: A simple guide and reference, 17.0 update. https://wps.ablongman.com/wps/media/objects/385/394732/george4answers.pdf
• GOLD (2011). Global strategy for the diagnosis, management and prevention of chronic obstruvtive pulmonary disease, www.goldcopd.org. Erişim tarihi: 05.09.2022.
• Hanlon P, Chadwick F, Shah A, Wood R, Minton J, McCartney G et al. (2020). COVID-19–exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5.
• Hasan SS, Capstick T, Zaidi STR, Kow CS & Merchant HA. (2020). Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respiratory Medicine, 170, 106045.
• Hu W, Dong M, Xiong M, Zhao D, Zhao Y, Wang M et al. (2020). Clinical courses and outcomes of patients with chronic obstructive pulmonary disease during the COVID-19 epidemic in Hubei, China. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2237.
• Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez et al (2021). Post-COVID-19 syndrome and the potential benefits of exercise. International Journal of Environmental Research and Public Health, 8(10), 5329.
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK. (2009). Development and first validation of the COPD assessment test. European Respiratory Journal, 34(3), 648-654.
• Kant A, Çomoğlu Ş, Öztürk S, Aydın E, Yılmaz G. (2020). Kronik obstrüktif akciğer hastalığı COVID-19 enfeksiyonunun şiddetini etkiliyor mu? Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 22(3), 440-444.
• Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. (1963). Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA, 185(12), 914-919.
• Kaya E, Özbek S, Tek A, Erg NS, Yaman NA. (2010). KOAH’lı yaşlı hastalarda günlük yaşam aktivitelerinin değerlendirilmesi. Türk Geriatri Dergisi, 13(2), 111-116.
• Lenz C, Slack MP, Shea KM, Reinert RR, Taysi BN, Swerdlow DL. (2023). Long-term effects of COVID-19: A review of current perspectives and mechanistic insights. Critical Reviews in Microbiology, 1-14.
• Liang Y, Chang C, Chen Y, Dong F, Zhang L, Sun Y. (2020). Symptoms, management and healthcare utilization of COPD patients during the COVID-19 epidemic in Beijing. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2487.
• Naing L, Winn T, Rusli BN (2006). Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences, 1, 9- 14.
• Pehlivanoğlu EFÖ, ÖzkanMU, Balcıoğlu H, Bilge U, Ünlüoğlu İ. (2018). Yaşlılar için katz günlük yaşam aktiviteleri ölçeğinin Türkçe’ye uyarlanması ve güvenilirliği. Ankara Medical Journal,18(2), 219-23. Scarlata S, Cardaci V, Santangelo C, Matarese M, Cesari M, Antonelli Incalzi R. (2021). Distancing measures in COVID-19 pandemic: Loneliness, more than physical isolation, affects health status and psycho-cognitive wellbeing in elderly patients with chronic obstructive pulmonary disease. COPD: Journal of Chronic Obstructive Pulmonary Disease, 18(4), 443-448.
• Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR et al. (2019). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD Science Committee Report 2019. European Respiratory Journal, 53(5),1900164.
• Turan MO, Balbay EG, Aksu K, Uzaslan E. (2022). COVID-19 pandemisinde astım, kronik obstrüktif akciğer hastalığı ve eşlik eden komorbiditelerin yönetimi: sistematik derleme. Turkiye Klinikleri Archives of Lung, 21(1), 29-38.
• WHO (2021). COVID-19 health system response monitor–United Kingdom. https://www.covid19healthsystem.org/countries/unitedkingdom/countrypage.aspx. Erişim tarihi: 04.03. 2022.
• Yorgancioğlu A, Polatli M, Aydemir Ö, Demirci NY, Kırkıl G, Atış SN ve ark. (2012). KOAH değerlendirme testinin Türkçe geçerlilik ve güvenilirliği. Tüberküloz ve Toraks, 60(4), 314-320.
• Zamzam MA, Azab NY, El Wahsh RA, Ragab AZ, Allam EM. (2012). Quality of life in COPD patients. Egyptian Journal of Chest Diseases and Tuberculosis, 61(4), 281-289.
• Zhou Z, Zhou A, Zhao Y, Duan J, Chen P. (2018). A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis. International Journal of Chronic Obstructive Pulmonary Disease, 13,1675-1682.